BR100 Increased By (0.11%)
BR30 Decreased By (-0.26%)
KSE100 Increased By (0.12%)
KSE30 Increased By (0.09%)
AGHA 7.81 Increased By ▲ 0.06 (0.77%)
BECO 5.21 Increased By ▲ 0.02 (0.39%)
BML 57.50 Decreased By ▼ -1.16 (-1.98%)
BOP 34.03 Increased By ▲ 0.34 (1.01%)
CNERGY 9.96 Decreased By ▼ -0.65 (-6.13%)
CSIL 5.31 Increased By ▲ 0.01 (0.19%)
FCCL 54.70 Increased By ▲ 0.96 (1.79%)
FFL 16.69 Increased By ▲ 0.23 (1.4%)
FNEL 1.23 Increased By ▲ 0.01 (0.82%)
KEL 7.40 Increased By ▲ 0.12 (1.65%)
KOSM 5.77 Increased By ▲ 0.13 (2.3%)
LOTCHEM 29.32 Decreased By ▼ -0.33 (-1.11%)
MLCF 94.36 Decreased By ▼ -2.00 (-2.08%)
NBP 203.05 Decreased By ▼ -0.48 (-0.24%)
NCPL 57.00 Increased By ▲ 0.15 (0.26%)
NPL 67.70 Increased By ▲ 0.39 (0.58%)
OGDC 315.84 Decreased By ▼ -2.38 (-0.75%)
PACE 10.64 Increased By ▲ 0.01 (0.09%)
PAEL 43.20 Increased By ▲ 1.43 (3.42%)
PIBTL 16.74 Decreased By ▼ -0.07 (-0.42%)
PPL 219.78 Decreased By ▼ -0.39 (-0.18%)
PRL 49.19 Increased By ▲ 0.14 (0.29%)
PTC 70.53 Increased By ▲ 0.52 (0.74%)
SSGC 28.25 Decreased By ▼ -0.89 (-3.05%)
TBL 9.86 Increased By ▲ 0.09 (0.92%)
TELE 8.79 Decreased By ▼ -0.03 (-0.34%)
TPL 18.24 Increased By ▲ 1.07 (6.23%)
TPLP 13.27 Increased By ▲ 0.76 (6.08%)
TREET 22.72 Increased By ▲ 0.13 (0.58%)
TRG 60.14 Decreased By ▼ -0.08 (-0.13%)
World

Norway says Moderna vaccine deliveries delayed by one week

  • There was supposed to have come 43,000 doses (next week), and those have been delayed to (the following week) according to our information.
  • As of Tuesday, close to 180,000 individuals in Norway had received their first dose of vaccine against the disease and close to 50,000 had received their second shot.
Published Updated
By

OSLO: Norway expects a shipment of COVID-19 vaccine from US drugmaker Moderna due next week to be delayed to the following week, the Norwegian Institute of Public Health (FHI) said on Wednesday.

"There was supposed to have come 43,000 doses (next week), and those have been delayed to (the following week) according to our information," FHI Department Director Line Vold told a news conference.

As of Tuesday, close to 180,000 individuals in Norway had received their first dose of vaccine against the disease and close to 50,000 had received their second shot.

Inoculations included vaccine made by Moderna and from a partnership between Pfizer and BioNTech, the agency said separately.

Comments

Comments are closed for this article.